Abstract:
This disclosure relates to methylsulfonamide derivatives and uses as imaging agents and other uses related to CXCR4 inhibition. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising compounds disclosed herein, derivatives, or pharmaceutically acceptable salts or prodrugs thereof. In certain embodiments, the compositions disclosed herein are used for imaging to study CXCR4 related conditions.
Abstract:
The present invention provides radiolabeled trimethoprim which are useful in imaging tests such as PET scans. The compounds show robust bacterial uptake in vitro and identify infections from inflammation or tumor when administered to a subject. The compounds show rapid and sensitive detection of Ec DHFR containing tumors from control tumors and background tissue. In one aspect, a compound having the structure of formula (I) is provided or a pharmaceutically acceptable salt or prodrug thereof, wherein R is defined herein. Also provided are compositions containing these compounds, positron emission tomography reporter probe comprising these compounds, and methods of imaging a bacterial infection, tracking or monitoring bacteria, distinguishing a bacterial infection from inflammation or tumor, monitoring genetically fused protein expression, and monitoring genetically engineered cells in clinical scenarios such as immunotherapy for cancer treatment.
Abstract:
The present invention is directed to CA I X inhibitors that conform to Formula 1 where the substituents X, A, B, D, E, E' and G are as defined above. Also described are Pt, 64 Cu, 186 Re, 188 Re and 99m Tc metal complexes of Formula 1 compounds which find use as candidate agents for imaging tumors.
Abstract:
The present invention describes oxidized avidin, suitable for inhalation, for conditioning the lung affected by inoperable/diffuse diseases, enabling the targeted delivery of biotinylated therapeutic agents to it.
Abstract:
The present invention provides novel radioiodinated fatty acids. Also provided are methods of preparation of said radioiodinated fatty acids from non-radioactive precursors, as well as radiopharmaceutical compositions comprising such radioiodinated fatty acids. The invention also provides in vivo imaging methods using the radioiodinated fatty acids.
Abstract:
The invention generally relates to the preparation of 18 F-!abeled radiopharmaceuticals. In particular, this invention relates to the advanced processes for an efficient eiution of [ 18 F]fluoride trapped in a cartridge filled with quaternary ammonium polymer which comprises inert non-basic and non-nucleophilic counter anions. The said methods and polymer cartridges allow the rapid preparation of suitable [ 18 F]fiuoride solution, which is also less basic to reduce the formation of byproducts, finally to increase radiochemical yield and purity of 18 F-radiopharmaceuticals.
Abstract:
The present invention relates to a new synthetic process in which an alkyne and an azide react to form a radioisotopic bioconjugate construct. The reaction is particularly useful for producing compounds for use in imaging and radiotherapy applications. The present invention also provides bioconjugate labels and further relates to the use of these compounds in diagnostic and therapeutic methods. In addition, the invention provides a related process for introducing a radioisotopic halogen atom into a terminal alkyne.
Abstract:
Provided in the following specification are precursors or synthons that are useful for the synthesis of various arabinose-based chemical and radiochemical derivatives of nitroimidazole-containing azomycin arabinosides, such as radioiodinated l-a-D-( 5-deoxy-5-[I*]- iodoarabinofuranosyl)-2-nitroimidazole (*IAZA), and radiofluorinated l-a-D-( 5-deoxy-5-[18F]-iodoarabinofuranosyl)-2-nitroimidazole ( 18FAZA). Such compounds are useful in imaging, therapy, or radiotherapy. Further, various syntheses of said precursors/synthons and the incorporation of said precursors/synthons into kits is provided. The precursors/ synthons provided herein allow for an improved and facile manufacturing process for nitroimidazole-containing azomycin arabinosides.
Abstract:
A molecular probe for use in the detection of myelin in a subject includes a compound having the general formula selected from the group consisting of: formula (I), and pharmaceutically acceptable salts thereof.